Anastom Surgical

Anastom Surgical is a French-based startup founded in 2012 that specializes in designing and bringing to market a range of medical devices for circular suturing, based on a unique and patented technology. The flagship product of Anastom Surgical is the UroLink, specifically tailored for prostate cancer ablation surgeries, addressing a prevalent condition affecting one in six men over 50 years old. The startup operates in the Health Care and Manufacturing industries, leveraging innovation in medical technology. With a focus on addressing a pressing medical need, Anastom Surgical offers specialized solutions for a significant health issue, demonstrating a clear market understanding and focus. With Anastom Surgical being based in France, it benefits from a prominent location in a leading European hub for innovation and healthcare. As of now, there is no publicly disclosed information regarding the last investment round or the participating investors. However, given its innovative approach and addressing a critical medical need, Anastom Surgical presents potential opportunities for investment in the healthcare technology sector.